COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients.

Katharina S. Shaw,Lu Yin,Jinal K Shah,Rachel Sally,Katerina Svigos,Prince Adotama,Hsiao Han Tuan,Jerry Shapiro,Rebecca A. Betensky,Kristen I Lo Siccoa

COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients.

2021

Katharina S. Shaw
Lu Yin
Jinal K Shah
Rachel Sally
Katerina Svigos
Prince Adotama
Hsiao Han Tuan
Jerry Shapiro
Rebecca A. Betensky
Kristen I Lo Siccoa

Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects.

Keywords:

Hydroxychloroquine
Internal medicine
MEDLINE
severe acute respiratory syndrome coronavirus 2
Medicine
Coronavirus disease 2019
Propensity score matching
Pandemic
2019 20 coronavirus outbreak

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations